Show simple item record

dc.contributor.authorO’Morain, N
dc.contributor.authorKumar, L
dc.contributor.authorO’Carroll-Lolait, C
dc.contributor.authorAlakkari, A
dc.contributor.authorRyan, B
dc.date.accessioned2019-03-25T12:42:27Z
dc.date.available2019-03-25T12:42:27Z
dc.date.issued2019-03
dc.identifier.urihttp://hdl.handle.net/10147/624143
dc.description.abstractBiologic therapies are increasingly used in the treatment of Inflammatory Bowel Disease. Reactions to infusion therapy are not uncommon but are mostly benign and self-limiting. Rarely, life-threatening complications can occur.en_US
dc.language.isoenen_US
dc.publisherIrish Medical Journalen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectINFLAMMATORY BOWEL DISEASEen_US
dc.subjectCARDIOLOGYen_US
dc.subjectGASTROENTEROLOGYen_US
dc.subjectSIDE EFFECTSen_US
dc.subjectINFUSION THERAPYen_US
dc.subjectHEARTen_US
dc.titleInfliximab Induced Cardiac Tamponadeen_US
dc.typeArticleen_US
dc.identifier.journalIrish Medical Journalen_US
dc.description.fundingNo fundingen_US
dc.description.provinceLeinsteren_US
dc.description.peer-reviewpeer-reviewen_US
refterms.dateFOA2019-03-25T12:42:28Z


Files in this item

Thumbnail
Name:
art10.html
Size:
32.87Kb
Format:
HTML
Description:
Main Article

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States